Subject(s)
Cardiovascular Agents/pharmacology , Coronary Artery Disease , Heart Failure , Heart Rate/drug effects , Coronary Artery Disease/complications , Coronary Artery Disease/drug therapy , Coronary Artery Disease/physiopathology , Disease Management , Drug Therapy, Combination , Health Services Needs and Demand , Heart Failure/complications , Heart Failure/drug therapy , Heart Failure/physiopathology , Humans , Patient Care Team/organization & administration , RussiaABSTRACT
Contemporary approach to antianginal therapy in patients with stable are reviewed. Benefits and limitations of "standard" antiischemic therapy and evidence-based data about alternative therapy with nicorandil are discussed in details.
Subject(s)
Coronary Artery Disease/drug therapy , Nicorandil/therapeutic use , Practice Guidelines as Topic , Vasodilator Agents/therapeutic use , Humans , Treatment OutcomeSubject(s)
Collateral Circulation , Counterpulsation , Myocardial Ischemia , Neovascularization, Physiologic , Aged, 80 and over , Coronary Circulation , Coronary Vessels/physiopathology , Counterpulsation/instrumentation , Counterpulsation/methods , Counterpulsation/trends , Heart-Assist Devices/trends , Humans , Male , Middle Aged , Myocardial Ischemia/physiopathology , Myocardial Ischemia/therapy , Russia , Severity of Illness Index , Treatment OutcomeSubject(s)
Fatty Acids, Omega-3 , Heart Failure , Medication Therapy Management , Cardiotonic Agents/administration & dosage , Cardiotonic Agents/pharmacology , Chronic Disease , Exercise Tolerance/drug effects , Fatty Acids, Omega-3/administration & dosage , Fatty Acids, Omega-3/adverse effects , Fatty Acids, Omega-3/pharmacology , Heart Failure/drug therapy , Heart Failure/mortality , Heart Failure/physiopathology , Heart Rate/drug effects , Hemodynamics/drug effects , Humans , Mortality , Myocardial Contraction/drug effects , Treatment OutcomeSubject(s)
Antihypertensive Agents , Blood Pressure/drug effects , Emergency Treatment , Hypertension, Malignant , Pre-Eclampsia/therapy , Acute Disease , Antihypertensive Agents/administration & dosage , Antihypertensive Agents/adverse effects , Blood Pressure Determination/methods , Blood Pressure Determination/standards , Emergency Treatment/classification , Emergency Treatment/methods , Emergency Treatment/standards , Female , Humans , Hypertension, Malignant/complications , Hypertension, Malignant/epidemiology , Hypertension, Malignant/physiopathology , Hypertension, Malignant/therapy , Hypertensive Encephalopathy/etiology , Hypertensive Encephalopathy/physiopathology , Hypertensive Encephalopathy/prevention & control , Intracranial Hemorrhage, Hypertensive/etiology , Intracranial Hemorrhage, Hypertensive/physiopathology , Intracranial Hemorrhage, Hypertensive/prevention & control , Male , Patient Education as Topic , Pre-Eclampsia/etiology , Pre-Eclampsia/physiopathology , Pregnancy , Preventive Medicine/methods , Russia/epidemiology , Secondary Prevention/education , Secondary Prevention/organization & administration , Treatment OutcomeSubject(s)
Acetazolamide , Carbonic Anhydrase Inhibitors , Cardiovascular Diseases/drug therapy , Acetazolamide/adverse effects , Acetazolamide/pharmacology , Acetazolamide/therapeutic use , Carbonic Anhydrase Inhibitors/adverse effects , Carbonic Anhydrase Inhibitors/pharmacology , Carbonic Anhydrase Inhibitors/therapeutic use , Clinical Trials as Topic , Humans , Treatment OutcomeABSTRACT
AIM: To analyse retrospectively quality of medical correction of modified risk factors (RF) and treatment of cardiovascular diseases (CVD) in patients with diabetes mellitus type (DM) 2 admitted to specialized endocrinological departments. MATERIAL AND METHODS: Analysis of medication policy of CVD RF was made retrospectively for 250 patients treated in endocrinological departments of Moscow hospital in 2003. RESULTS: Arterial hypertension, coronary heart disease were diagnosed in 93.2 and 87.2% examinees. History of myocardial infarction and brain stroke was in 8.4 and 6% patients. Statins were prescribed in 2.4% cases. Examination for dyslipidemia was not satisfactory. ACE inhibitors were prescribed in 71.2% patients. Aspirin was prescribed (18%) primarily by the cardiologist. CONCLUSION: Quality of medical prophylaxis of CVD RF in DM type 2 patients in the departments does not satisfy modern clinical recommendations.